Pfizer Begins Building a COVID-19 Distribution Chain
Laying the Groundwork
Pfizer (PFE) is in the process of building a vaccine supply chain in order to be prepared for if and when a long-awaited COVID-19 vaccine is ready for distribution. The pharmaceutical superpower is laying the groundwork to be able to allocate 100 million doses of the vaccine in 2020 and 1.3 billion doses in 2021.
Pfizer is collaborating with German company BioNTech (BNTX) on an experimental COVID-19 vaccine which is in late-stage testing. Pfizer says it could know whether its vaccine is effective by late October, and it could be ready to apply for emergency-use authorization for the vaccine by the end of November. So far, Pfizer has spent about $2 billion on developing the vaccine and making preparations to distribute it.
Pfizer’s vaccine distribution strategy is centered around two enormous, refrigerated storage sites—one in Kalamazoo, Michigan and one in Puurs, Belgium. Dozens of daily cargo-jet flights and hundreds of daily truck trips would move the vaccine from these centers to people around the world. The company has created a reusable refrigerated storage container that can hold 1,000 to 5,000 doses of the vaccine and can keep it cold for up to ten days.
Under normal circumstances, a pharmaceutical company would wait to put a distribution chain in place until its vaccine was approved. However, time is of the essence when it comes to distributing a COVID-19 vaccine, and companies are forgoing normal timelines.
Governments Have Ordered Hundreds of Millions of Vaccine Doses
Governments around the world have already made deals with Pfizer and other companies working on vaccines for if and when their products are ready for distribution.
The US government has ordered 100 million doses of the Pfizer vaccine with the option to buy 500 million additional doses. The EU has reached an agreement to buy 200 million doses with the option for an additional 100 million. Japan has ordered 120 million doses.
Though there are still many steps to be taken before a vaccine is ready for distribution, Pfizer is making sure it has a robust supply chain in place so that it will be ready to distribute the vaccine as quickly as possible if it is successfully tested and approved.
Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.